22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › WEST PHARMACEUTICAL SERVICES INC. › 2024-2025

WEST PHARMACEUTICAL SERVICES INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and WEST PHARMACEUTICAL SERVICES INC.’s Form 8-K, filed May 8, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 16Ballot items
  • 717Asset managers, any item
  • 11,535Fund votes
  • May 6, 2025Meeting date

Results at a glance

Meeting of May 6, 2025: 16 items on WEST PHARMACEUTICAL SERVICES INC.’s Form 8-K, filed May 8, 2025: 12 elected · 4 approved.

Dissent

Notable dissent: 1 director (11.8% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore WEST PHARMACEUTICAL SERVICES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by WEST PHARMACEUTICAL SERVICES INC.

These tallies are WEST PHARMACEUTICAL SERVICES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 8, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

WEST PHARMACEUTICAL SERVICES INC. — official shareholder meeting results, meeting held May 6, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Mark A. Buthman 61,532,8021,245,67082,208 --2,153,564 98%Elected—
Elect Director: William F. Feehery 60,733,0342,055,57672,070 --2,153,564 97%Elected—
Elect Director: Robert F. Friel 61,263,5411,514,60182,538 --2,153,564 98%Elected—
Elect Director: Eric M. Green 57,172,1365,326,139362,405 --2,153,564 91%Elected—
Elect Director: Janet B. Haugen 60,548,3122,279,20233,166 --2,153,564 96%Elected—
Elect Director: Thomas W. Hofmann 58,015,3094,679,404165,967 --2,153,564 93%Elected—
Elect Director: Molly E. Joseph 62,289,941530,57640,163 --2,153,564 99.2%Elected—
Elect Director: Deborah L. V. Keller 55,149,8067,367,368343,506 --2,153,564 88%Elected—
Elect Director: Myla P. Lai-Goldman 61,584,8791,254,54221,259 --2,153,564 98%Elected—
Elect Director: Stephen H. Lockhart 62,513,899264,30882,473 --2,153,564 99.6%Elected—
Elect Director: Douglas A. Michels 59,815,6982,962,81482,168 --2,153,564 95%Elected—
Elect Director: Paolo Pucci 61,243,7821,534,34482,554 --2,153,564 98%Elected—
Our shareholders approved, on an advisory basis, our named executive officer compensation 59,222,3383,516,476121,866 --2,153,564 94%Approved—
Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders to call a special meeting 62,707,01788,40065,263 --2,153,564 99.9%Approved—
Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan 60,862,0531,883,395115,232 --2,153,564 97%Approved—
Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year 60,537,2214,373,036103,987 ---- 93%Approved—

Source: WEST PHARMACEUTICAL SERVICES INC., Form 8-K, filed with the SEC on May 8, 2025 — read the filing on EDGAR.

How asset managers voted at the WEST PHARMACEUTICAL SERVICES INC. 2024-2025 meeting

717 asset managers disclosed a vote on at least one WEST PHARMACEUTICAL SERVICES INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Deborah L. V. Keller

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 55,149,806AGAINST: 7,367,368

Prior year: 86.5% for (April 23, 2024 meeting) ▲ 1.7 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Deborah L. V. Keller

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Deborah L. V. Keller”): 55,149,806 for, 7,367,368 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 24,518,689 for, 2,722,848 against, 1,826 abstained.

FOR
FOR: 24,518,689AGAINST: 2,722,848ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Deborah L. V. Keller” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,505779 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST0858,500 00Against
State Street792,8050 00For
VanEck ETF Trust0601,939 00Against
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds0260,256 00Against
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Douglas A. Michels

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 59,815,698AGAINST: 2,962,814

Prior year: 94.0% for (April 23, 2024 meeting) ▲ 1.3 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Douglas A. Michels

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Douglas A. Michels”): 59,815,698 for, 2,962,814 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 26,755,124 for, 486,413 against, 1,826 abstained.

FOR
FOR: 26,755,124AGAINST: 486,413ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Douglas A. Michels” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,881403 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00Mixed
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Eric M. Green

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

91% Majority: yes · of votes cast

FOR 91%
FOR: 57,172,136AGAINST: 5,326,139

Prior year: 95.7% for (April 23, 2024 meeting) ▼ 4.2 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Eric M. Green

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Eric M. Green”): 57,172,136 for, 5,326,139 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 26,767,613 for, 473,924 against, 1,826 abstained.

FOR
FOR: 26,767,613AGAINST: 473,924ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Eric M. Green” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00Mixed
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Janet B. Haugen

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 60,548,312AGAINST: 2,279,202
Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Janet B. Haugen

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Janet B. Haugen”): 60,548,312 for, 2,279,202 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,241,486 for, 51 against, 1,826 abstained.

FOR
FOR: 27,241,486AGAINST: 51ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Janet B. Haugen” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Mark A. Buthman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,532,802AGAINST: 1,245,670

Prior year: 98.8% for (April 23, 2024 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Mark A. Buthman

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Mark A. Buthman”): 61,532,802 for, 1,245,670 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,205,840 for, 25,763 against, 11,760 abstained.

FOR
FOR: 27,205,840AGAINST: 25,763ABSTAIN: 11,760
Largest asset managers voting on “Election of Directors: Mark A. Buthman” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00Mixed
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Molly E. Joseph

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%
FOR: 62,289,941AGAINST: 530,576

Prior year: 99.3% for (April 23, 2024 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Molly E. Joseph

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Molly E. Joseph”): 62,289,941 for, 530,576 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,229,816 for, 1,787 against, 11,760 abstained.

FOR
FOR: 27,229,816AGAINST: 1,787ABSTAIN: 11,760
Largest asset managers voting on “Election of Directors: Molly E. Joseph” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Myla P. Lai-Goldman

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,584,879AGAINST: 1,254,542

Prior year: 99.2% for (April 23, 2024 meeting) ▼ 1.2 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Myla P. Lai-Goldman

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Myla P. Lai-Goldman”): 61,584,879 for, 1,254,542 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,209,239 for, 32,298 against, 1,826 abstained.

FOR
FOR: 27,209,239AGAINST: 32,298ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Myla P. Lai-Goldman” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00Mixed
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Paolo Pucci

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,243,782AGAINST: 1,534,344

Prior year: 92.5% for (April 23, 2024 meeting) ▲ 5.1 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Paolo Pucci

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Paolo Pucci”): 61,243,782 for, 1,534,344 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 26,781,831 for, 459,706 against, 1,826 abstained.

FOR
FOR: 26,781,831AGAINST: 459,706ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Paolo Pucci” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,881403 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Robert F. Friel

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 61,263,541AGAINST: 1,514,601

Prior year: 95.2% for (April 23, 2024 meeting) ▲ 2.4 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Robert F. Friel

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Robert F. Friel”): 61,263,541 for, 1,514,601 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 26,781,831 for, 459,706 against, 1,826 abstained.

FOR
FOR: 26,781,831AGAINST: 459,706ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Robert F. Friel” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,881403 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert0437,520 00Against
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Stephen H. Lockhart

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 62,513,899AGAINST: 264,308

Prior year: 99.7% for (April 23, 2024 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Stephen H. Lockhart

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Stephen H. Lockhart”): 62,513,899 for, 264,308 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,241,486 for, 51 against, 1,826 abstained.

FOR
FOR: 27,241,486AGAINST: 51ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Stephen H. Lockhart” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: Thomas W. Hofmann

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 58,015,309AGAINST: 4,679,404

Prior year: 92.8% for (April 23, 2024 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: Thomas W. Hofmann

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: Thomas W. Hofmann”): 58,015,309 for, 4,679,404 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,166,809 for, 74,728 against, 1,826 abstained.

FOR
FOR: 27,166,809AGAINST: 74,728ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: Thomas W. Hofmann” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00Mixed
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Elect Director: William F. Feehery

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 60,733,034AGAINST: 2,055,576

Prior year: 97.0% for (April 23, 2024 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 156 asset managers

Description as filed by funds: Election of Directors: William F. Feehery

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Elect Director: William F. Feehery”): 60,733,034 for, 2,055,576 against, per its Form 8-K filed May 8, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2026 Annual Meeting of Shareholders by the following vote:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 156 asset managers below reported 27,214,046 for, 27,491 against, 1,826 abstained.

FOR
FOR: 27,214,046AGAINST: 27,491ABSTAIN: 1,826
Largest asset managers voting on “Election of Directors: William F. Feehery” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00Mixed
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 156 asset managers. All 156 are in the interactive database (link above).

Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 62,707,017AGAINST: 88,400
Details: description as filed, official tally, votes by 157 asset managers

Description as filed by funds: Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a Special Meeting;

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 3: Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders to call a special meeting by the following vote:”): 62,707,017 for, 88,400 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Our shareholders approved an amendment and restatement of our Articles of Incorporation to add a right for shareholders to call a special meeting by the following vote:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 157 asset managers below reported 27,211,628 for, 29,983 against, 1,826 abstained.

FOR
FOR: 27,211,628AGAINST: 29,983ABSTAIN: 1,826
Largest asset managers voting on “Amend and Restate Our Amended and Restated Articles of Incorporation to Add a Right For Shareholders to call a” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,616668 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 157 asset managers. All 157 are in the interactive database (link above).

Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan

Official resultCOMPENSATIONReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 60,862,053AGAINST: 1,883,395
Details: description as filed, official tally, votes by 172 asset managers

Description as filed by funds: Amend and Restate Our 2016 Omnibus Incentive Compensation Plan; and

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 4: Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan by the following vote:”): 60,862,053 for, 1,883,395 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4: Our shareholders approved the amendment and restatement of our 2016 Omnibus Incentive Compensation Plan by the following vote:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 172 asset managers below reported 26,800,817 for, 496,268 against, 1,826 abstained.

FOR
FOR: 26,800,817AGAINST: 496,268ABSTAIN: 1,826
Largest asset managers voting on “Amend and Restate Our 2016 Omnibus Incentive Compensation Plan; and” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust351,47825,657 00Mixed
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century0336,760 00Against
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 172 asset managers. All 172 are in the interactive database (link above).

Our shareholders approved, on an advisory basis, our named executive officer compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

94% Approved · of votes cast

FOR 94%
FOR: 59,222,338AGAINST: 3,516,476

Prior year: 95.5% for (April 23, 2024 meeting) ▼ 1.1 pts

Details: description as filed, official tally, votes by 711 asset managers

Description as filed by funds: Advisory vote to approve named executive officer compensation.

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”): 59,222,338 for, 3,516,476 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 155 asset managers voting on “Advisory vote to approve named executive officer compensation.” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,753,616668 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,41972 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century119336,641 00Against
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Fund voting reports, all 155 managers: 26,751,846 for, 471,230 against, 1,826 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 588 asset managers voting on “Advisory vote to approve named executive officer compensation.” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BROWN ADVISORY INC3,263,5450 00For
BlackRock2,837,1561,312 00For
Artisan2,118,5470 00For
Walter Scott & Partners Ltd1,983,7030 00For
State Street1,977,5840 00For
GEODE CAPITAL MANAGEMENT, LLC1,822,3130 00For
FRANKLIN ADVISERS INC1,556,6660 00For
APG Asset Management US Inc.01,552,743 00Against
Fidelity834,8320 00For
Findlay Park Partners LLP828,6060 00For
Durable Capital Partners LP752,8400 00For
T. Rowe Price715,4140 00For
Invesco668,924277 00For
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC631,1630 00For
Northern Trust625,1950 00For
VAN ECK ASSOCIATES CORP603,2350 00For
JPMorgan536,9610 00For
Charles Schwab485,0640 00For
Point72480,2700 00For
UBS460,9040 00For
Seilern Investment Management Ltd452,7210 00For
Vanguard448,1340 00For
Calvert440,0270 00For
DF DENT & CO INC436,8320 00For
Capital Research Global Investors389,5350 00For

Institutional-manager reports, all 588 managers: 38,307,649 for, 2,717,428 against, 6,699 abstained, 9,811 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 5 wordings of this item as funds reported it.

93% Approved · of votes cast

FOR 93%
FOR: 60,537,221AGAINST: 4,373,036

Prior year: 91.8% for (April 23, 2024 meeting) ▲ 1.5 pts

Details: description as filed, official tally, votes by 154 asset managers

Description as filed by funds: Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm FOR 2025.

WEST PHARMACEUTICAL SERVICES INC.’s own tally for this item (“Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year by the following vote:”): 60,537,221 for, 4,373,036 against — passed, per its Form 8-K filed May 8, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year by the following vote:”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 154 asset managers below reported 27,121,058 for, 105,494 against, 1,826 abstained.

FOR
FOR: 27,121,058AGAINST: 105,494ABSTAIN: 1,826
Largest asset managers voting on “Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting ” at WEST PHARMACEUTICAL SERVICES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard8,718,3100 00For
BlackRock2,754,2840 00For
Fidelity2,435,0650 00For
Brown Advisory Funds1,043,5510 00For
FRANKLIN MANAGED TRUST858,5000 00For
State Street792,8050 00For
VanEck ETF Trust601,9390 00For
Invesco570,4910 00For
Artisan569,2250 00For
ProShares504,5010 00For
Charles Schwab478,6830 00For
Calvert437,5200 00For
AMCAP FUND380,6990 00For
Bridge Builder Trust377,1350 00For
JPMorgan361,5160 00For
Principal351,7790 00For
T. Rowe Price345,2540 00For
American Century336,7600 00For
Virtus330,1890 00For
Jackson National312,2270 00For
TIAA275,9000 00For
Franklin Custodian Funds260,2560 00For
BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND)236,4040 00For
Neuberger Berman227,8580 00For
Goldman Sachs221,9310 00For

Showing the 25 largest of 154 asset managers. All 154 are in the interactive database (link above).

Largest WEST PHARMACEUTICAL SERVICES INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 71,800,000 shares outstanding at the time of that meeting.

Fund voting reports: top WEST PHARMACEUTICAL SERVICES INC. shareholders by shares voted on “Advisory vote to approve named executive officer compensation.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 12.14%
2BlackRock 3.84%
3Fidelity 3.39%
4Brown Advisory Funds 1.45%
5FRANKLIN MANAGED TRUST 1.20%
6State Street 1.10%
7VanEck ETF Trust 0.84%
8Invesco 0.79%
9Artisan 0.79%
10ProShares 0.70%
Institutional-manager reports: top WEST PHARMACEUTICAL SERVICES INC. shareholders by shares voted on “Advisory vote to approve named executive officer compensation.”, 2024-2025
#Asset manager % of shares outstanding
1BROWN ADVISORY INC 4.55%
2BlackRock 3.95%
3Artisan 2.95%
4Walter Scott & Partners Ltd 2.76%
5State Street 2.75%
6GEODE CAPITAL MANAGEMENT, LLC 2.54%
7FRANKLIN ADVISERS INC 2.17%
8APG Asset Management US Inc. 2.16%
9Fidelity 1.16%
10Findlay Park Partners LLP 1.15%

Reported WEST PHARMACEUTICAL SERVICES INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

WEST PHARMACEUTICAL SERVICES INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vanguard Group9,231,721 12.86%Form 13F, quarter ended March 31, 2025
BlackRock6,930,119 9.65%Form 13F, quarter ended March 31, 2025
BNY Mellon3,375,321 4.70%Form 13F, quarter ended March 31, 2025
State Street3,203,536 4.46%Form 13F, quarter ended March 31, 2025
Geode Capital1,853,693 2.58%Form 13F, quarter ended March 31, 2025
Franklin Templeton1,560,597 2.17%Form 13F, quarter ended March 31, 2025
Morgan Stanley1,285,346 1.79%Form 13F, quarter ended March 31, 2025
Invesco949,455 1.32%Form 13F, quarter ended March 31, 2025
Norges Bank897,537 1.25%Form 13F, quarter ended March 31, 2025
Northern Trust758,246 1.06%Form 13F, quarter ended March 31, 2025

Percentages above are of 71,800,000 shares outstanding, as reported by WEST PHARMACEUTICAL SERVICES INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At WEST PHARMACEUTICAL SERVICES INC.'s shareholder meeting held May 6, 2025, in the 2024-2025 proxy season, 717 asset managers reported votes on at least one of its 16 ballot items in their SEC Form N-PX filings, covering 11,535 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve named executive officer compensation. — WEST PHARMACEUTICAL SERVICES INC.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: WEST PHARMACEUTICAL SERVICES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 8, 2025.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from WEST PHARMACEUTICAL SERVICES INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

WEST PHARMACEUTICAL SERVICES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “WEST PHARMACEUTICAL SERVICES (WST) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/west-pharmaceutical-services-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.